Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GT 2227

Known as: GT-2227 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Dynamics of histamine H(3) receptor antagonists on brain histamine metabolism: do all histamine H(3) receptor antagonists act at a single site?
Thioperamide, the prototypical histamine H(3) receptor antagonist, acts at the brain histamine H(3) autoreceptor to promote the… Expand
1999
1999
Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
A new series of 1H-4-substituted imidazole compounds were synthesized and identified as potent and selective histamine (HA) H3… Expand
  • figure 2
  • figure 1
  • table 1
  • table 2
  • table 3
1999
1999
Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex.
The H3 antagonist thioperamide is thought to act on brain H3 autoreceptors to increase both the release and metabolism of… Expand
1998
1998
High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.
GT-2227 (4-(6-cyclohexylhex-cis-3-enyl)imidazole) and GT-2331 ((1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole) were… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE